Dr. Ed Park of Recharge Biomedical explains vision and describes two cases of improvement after exosomes. (n.b. Exosomes are not FDA-approved to treat vision problems)
Dr. Ed Park of Recharge Biomedical explains face blindness, or prosopagnosia, which affects about one in fifty people. A case of significant improvement after exosome treatment is presented. (n.b. Exosomes are not FDA-approved to treat face blindness)
Dr. Ed Park of Recharge Biomedical addresses FAQs about exosome treatments. How are they different from stem cells? Are they FDA-approved? How much does it cost? What are his results?